During an Atherosclerotic Cardiovascular Disease (ASCVD) clinical trial, participants undergo various assessments, tests, and procedures as part of the study protocol. The specific activities and interventions involved in the trial may vary depending on the study’s objectives and the investigational treatments being evaluated.
Atherosclerotic Cardiovascular Clinical Trials in Oklahoma City
Clinical Trials on Atherosclerotic Disease, where your involvement will contribute to better health outcomes.
Enroll Now
Living With Heart Conditions?
You might qualify for atherosclerotic cardiovascular disease research.
Heart diseases, including atherosclerotic cardiovascular diseases, remain prominent causes of mortality among both men and women in the United States. Despite medical progress, a demand for improved treatments to prevent and address cardiovascular conditions persists.
At Hightower, we’re currently conducting atherosclerotic cardiovascular clinical trials to assess the safety and efficacy of an experimental drug in individuals with cardiovascular diseases.
*Participation in the Clinical Trial is completely free of cost and is your choice.
*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.
Study Information
Atherosclerotic Cardiovascular Disease
| Study Name | Protocol Number | Sponsor |
|---|---|---|
| ESPRIT | ABT-CRD-1061 | Abbott |
About Atherosclerotic Cardiovascular Clinical Trials
In partnership with pharmaceutical companies, Hightower is conducting a cardiovascular disease research study to evaluate the safety and efficacy of an investigational medicine for individuals with cardiovascular conditions, including peripheral artery disease (PAD).
This Phase 3 atherosclerotic cardiovascular clinical trial aims to determine whether the investigational oral medication can effectively reduce the risk of CV death, non-fatal myocardial infarction (MI), non-fatal ischemic stroke, and urgent coronary revascularization.
Participants will be randomly assigned to one of two groups: one receiving the investigational drug and the other receiving a placebo.
*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.
*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.
Atherosclerosis Research: What to Expect?
Upon agreeing to participate in the study, you’ll be requested to sign an Informed Consent Form containing comprehensive details about the study. Our research study team will also provide guidance on the study process and your role in the trials. We strongly encourage participants to ask any questions they may have before making their decision to participate or withdraw from the trial.
Once the consent form is signed and all inquiries are addressed, participants will be randomly assigned to one of two groups: the Control or Experimental groups.
In the Control group, participants receive a placebo medication lacking active ingredients, while the Experimental group receives the actual study drug containing active ingredients. This study employs a double-blind design, meaning neither the researcher nor the participant knows which treatment or intervention is being administered.
* Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.
Age
40 Years to 79 Years
Gender
Male & Female
Condition
ASCVD
Current Status
Recruiting
What Happens in ASCVD?
The culprit behind ASCVD is the build-up of fatty deposits, cholesterol, and other substances called plaque within the walls of your arteries. This process, known as atherosclerosis, gradually narrows the arteries, hindering blood flow.
Complications
- Coronary artery disease (CAD): Plaque build-up in the arteries supplying your heart can lead to chest pain (angina), heart attack, and heart failure.
- Stroke: When plaque breaks off and travels to the brain, it can block blood flow and cause a stroke.
- Peripheral artery disease (PAD): Reduced blood flow to the legs and feet can cause pain, cramping, and even tissue death.
Symptoms
- Chest pain (angina): This can feel like pressure, tightness, or squeezing in your chest. It’s often triggered by exertion and relieved by rest.
- Shortness of breath: This may occur during activity or even at rest in severe cases.
- Fatigue: You may feel unusually tired or exhausted.
- Pain in your upper body: This pain can radiate to your arms, neck, jaw, or back.
- Nausea or vomiting: This can be mistaken for indigestion.
- Dizziness or lightheadedness: This can signal reduced blood flow to the brain.
Frequently Asked Questions
What if I have other medical conditions? Can I still participate in an ASCVD clinical trial?
Whether individuals with other medical conditions can participate in an Atherosclerotic Cardiovascular Disease (ASCVD) clinical trial depends on several factors, including the specific eligibility criteria of the trial, the nature and severity of their other medical conditions, and the potential impact of those conditions on the study outcomes and participant safety.
Why participate in an ASCVD clinical trial?
Participating in an ASCVD clinical trial offers the opportunity to access cutting-edge treatments, contribute to medical research, receive expert medical care, and potentially achieve better health outcomes.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.